MOLINA HEALTHCARE, INC. 8-K

What Happened
Molina Healthcare, Inc. announced in an 8-K that at its Annual Meeting on May 6, 2026, stockholders approved an amendment to the Molina Healthcare 2025 Equity Incentive Plan increasing the number of shares authorized for issuance by 1,500,000 shares, bringing the total to 3,295,000 shares. The amendment had been approved by the Board subject to stockholder approval and is described in the company’s definitive proxy statement filed March 23, 2026; the text of the amendment is filed as Exhibit 10.1 to the 8-K.

The filing also includes exhibits reflecting corporate document changes (Certificate of Amendment to the Certificate of Incorporation and Amended and Restated Bylaws filed as Exhibits 3.1 and 3.2). The 8-K was filed May 11, 2026 and signed by Jeff D. Barlow, Chief Legal Officer and Secretary.

Key Details

• Annual Meeting date: May 6, 2026. 8‑K filed May 11, 2026.
• Equity plan increase: +1,500,000 shares, new total authorized = 3,295,000 shares under the 2025 Equity Incentive Plan.
• Amendment text filed as Exhibit 10.1; related corporate charter and bylaw amendments filed as Exhibits 3.1 and 3.2.
• Proxy Statement describing the amendment: filed March 23, 2026.

Why It Matters
Approving more shares under the equity incentive plan gives Molina additional capacity for stock-based awards (e.g., options, restricted stock) used for compensation and retention. For investors, that can mean potential future dilution if awards are granted and shares are issued; the size of the increase (1.5M shares) is a concrete figure to monitor against outstanding shares and potential grant activity. The filed amendment and bylaws/certificate changes should be reviewed (Exhibits 10.1, 3.1, 3.2) for full terms and governance impacts.